Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 Gangliosidosis
Ontology highlight
ABSTRACT:
INSTRUMENT(S): Orbitrap Fusion Lumos
ORGANISM(S): Mus Musculus (ncbitaxon:10090)
SUBMITTER: 
Jennifer Brodbelt
PROVIDER: MSV000092791 | MassIVE | Wed Aug 30 09:16:00 BST 2023
REPOSITORIES: MassIVE
Similar Datasets
Project description:Three runs for each sample for quantitation (MS1 spectra only) which are dated 20230716. One run for each sample for identification with UVPD. Peak area was quantified using the Genesis algorithm in QualBrowser.
2023-08-30 | MSV000092791 | GNPS
Project description:This dataset derives from experiments testing quantitation using label-free methods. We used the Sigma-Aldrich UPS1 and UPS2 protein standard sets, containing proteins of 6-83 kD; the UPS1 set includes 49 human proteins at a single molar concentration, while the UPS2 set includes six groups of eight human proteins spanning a six orders of magnitude in concentration. In both cases, dilutions of UPS1 or UPS2 proteins were made into an E. coli extract, which allows these experiments to mimic detection of low abundance proteins in a complex protein mixture. The UPS1/E. coli and UPS2/E. coli mixtures were run on three mass spectrometers, an Orbitrap Velos Elite and two ion-trap instruments (Velos and LTQ). Proteins were quantified using MS1 peak volume (Orbitrap) or MS2 intensities and spectral counts (Orbitrap, Velos, LTQ). The analyzed results show that the ion-trap instruments perform nearly as well for label-free quantitation as does the Orbitrap. In addition, the \"Top 3\" method for quantitation—measuring only the three most abundant peptides—performed no better than the \"iBAQ\" quantitation method. Data analysis: MS1 data were analyzed using MaxQuant. MaxQuant version 1.2.2.5 software was used for protein identification and quantitation. Using the search engine Andromeda, mass spectrometry data were searched against the database containing UPS and E. coli proteins. MaxQuant reports summed intensity for each protein, as well as its iBAQ value. In the iBAQ algorithm, the intensities of the precursor peptides that map to each protein are summed together and divided by the number of theoretically observable peptides, which is considered to be all tryptic peptides between 6 and 30 amino acids in length. This operation converts a measure that is expected to be proportional to mass (intensity) into one that is proportional to molar amount (iBAQ). To determine relative molar abundances for each E. coli and human protein using MS1 data, two methods were used. In the first, we determined each proteins relative iBAQ (riBAQ), a normalized measure of molar abundance. We removed from the analysis all contaminant proteins that entered our sample-preparation workflow, for example keratins and trypsin, and then divided each remaining proteins iBAQ value by the sum of all non-contaminant iBAQ values. We also measured the average intensity of the three (or fewer, if fewer peptides were detected) peptides with the highest intensity, Top3, for each protein detected9. Peptides were chosen separately for each experiment, so the same peptides were not necessarily used across the four experiments. We generated a normalized \"top three\" abundance factor by dividing the average intensity for the three most abundant peptides of an individual protein and by the sum of all Top3 values in an experiment. Peptide intensities were summed for all charge states and variable modifications. For MS2 label-free analysis with MS2 spectra, MS2 data were searched against the database described above using SEQUEST. Setting to 1% the peptide false-discovery rate, estimated using a decoy (reversed) database, proteins were identified using the PAW pipeline. Normalized molar intensity (im) was calculated by dividing i, the summed intensity for an individual protein, by its molecular mass; the i/mr value for each protein was divided by the sum of all i/mr values. Normalized molar counts (cm) were calculated similarly, except the summed spectral counts for a protein (c) was used instead.
2013-12-05 | PXD000602 | Pride
Project description:We developed a large animal model, with clinically relevant gravitational loading on the lymphatic vasculature, that enables longitudinal tracking of lymphatic function in vivo as well as end-point analysis of vessel function and mechanics. One of two parallel lymphatic vessels in the sheep hind limb was ligated with the contralateral limb acting as an internal control. To determine the changes in the protein expression profiles in the lymphatic muscle cells from the remodeled vessel compared to the control, we expanded isolated LMC in vitro and performed bottom-up proteomic analysis using a Q Exactive Plus mass spectrometer. Label-free quantitative (LFQ) methods directly used the raw spectral data from parallel MS runs to determine relative protein abundances. We used both “MS/MS (MS2) spectral counting” and “precursor MS1 area” methods for label free quantitation and further contrasting the differentially expressed proteomic profiles across the control and remodeled lymphatic muscle samples to determine the alterations in mitochondrial dysfunction and elevated oxidative stress within the lymphatic muscle.
2021-01-12 | PXD014343 | Pride
Project description:When evaluating the quantitative performance of label-free proteomics method(s), samples with known compositions are necessary to define key parameters such as reproducibility, missing data levels, accuracy, precision, as well as sensitivity/specificity for biomarker discovery. Here, we provide a carefully-designed multi-species spike-in sample set for such purposes, which was prepared by spiking small, variable amounts of E. Coli (for mimicking significant protein changes, i.e., true positives) and yeast (for balancing the variable levels of E. coli proteins) proteins into a large, constant background of human proteins (representing unchanged proteins). The sample set encompasses a total of 25 LC-MS sample runs (5 E.coli-level groups, 5 LC-MS replicate runs in each group). The proportion of human proteins is 60% across all samples, and each group contains the following percentage of E. coli and yeast proteins : A: 5%/35%, B: 7.5%/32.5%, C: 10%/30%, D: 15%/25%, E: 20%/20%. These files were used to comprehensively evaluate the quantitative performances by ultra-high-resolution (UHR)-IonStar and SWATH-MS in Result 3.2 of “Ultra-High-Resolution IonStar Strategy Enhancing Accuracy and Precision of MS1-Based Proteomics and an Extensive Comparison with State-of-the-Art SWATH-MS in Large-Cohort Quantification (DOI: 10.1021/acs.analchem.0c05002)”.
2022-01-06 | PXD030780 | Pride
Project description:Stochasticity between independent LC-MS/MS runs is a challenging problem in the field of proteomics resulting in significant missing values (i.e., abundance measurements) among observed peptides. To address this issue, several approaches have been developed including computational methods such as MaxQuant’s Match-Between-Runs (MBR) algorithm. Often dozens of runs are all considered at once by MBR, transferring identifications from any one run to any of the others. To evaluate the error associated with these transfer events, we created a two-sample/two-proteome approach. In this way, samples containing no yeast lysates were assessed for false identification transfers from samples containing yeast. Overall, transfers from any of 20 runs with yeast were assessed to any of 20 runs without yeast were measured. While MBR increased the total number of spectral identifications by ~40%, we also found that 44% of all identified yeast proteins had identifications transferred to at least one sample without yeast. However, of these only 2.7% remained in the final dataset after applying the MaxQuant LFQ algorithm. We conclude that false transfers by MBR are plentiful, but likely have only a small impact on the final dataset due to downstream removal.
2019-09-25 | PXD014415 | Pride
Project description:This is a miRNA expression analysis by microarray. Comparison was made beween Ulcerative Colitis (UC) vs control, Active UC vs Remission, Ascending Colon vs Rectosigmoid area of Colon. The samples were labeled using the miRCURY LNA™ microRNA Hi-Power Labeling Kit, Hy3™/Hy5™ and hybridized on the miRCURY LNA™ microRNA Array (7th gen) following the scheme you outlined in the sample submission form. The technical data quality assessment showed that the labeling was successful as all capture probes for the control spike-in oligo nucleotides produced signals in the expected range. Following normalization of the quantified signals (background corrected) using the global Lowess regression algorithm, we have performed an unsupervised as well as supervised data analysis.
2015-11-02 | GSE66932 | GEO
Project description:Male house mice were housed under semi-natural conditions and their urinary proteins were quantified using MS1 and MS2 based label-free strategies. This dataset consists of 52 raw MS files, comprising 26 DIA (SWATH) and 26 IDA runs on a TripleTOF 5600. The composition of the dataset is described in the manuscript by Enk et al., titled: "Regulation of highly homologous Major Urinary Proteins in house mice quantified with label-free proteomic methods ", Molecular Biosystems, in review.
2016-08-08 | PXD004642 | Pride
Project description:A Brunello CRISPR-Cas9 library screen was performed with OVCAR3 and CCL218 cells in the presence or absence of hydroxychloroquine. Drug pulse chases were used, with 48h of drug exposure followed by replacement of fresh media. Cells were allowed to grow to near confluence and then another drug pulse-chase was performed. After each pulse-chase, a pool of cells were collected for sgRNA quantitation. Three pulse chases were performed. Cell pellets were processed for genomic DNA and sgRNA sequences amplified by PCR for NGS-based quantitation. Once quantified by NGS analysis, MAGeCK MLE analysis was performed to determine which sgRNAs were most associated with resistance or sensitization to hydroxychloroquine.
2024-03-18 | GSE245215 | GEO
Project description:Quantitative cross-linking/mass spectrometry (QCLMS) is an emerging approach to study conformational changes of proteins and multi-subunit complexes. Distinguishing protein conformations requires reproducibly identifying and quantifying cross-linked peptides. Here we analyzed the variation between multiple cross-linking reactions using bis[sulfosuccinimidyl] suberate (BS3)-cross-linked human serum albumin (HSA) and evaluated how reproducible cross-linked peptides can be identified and quantified by LC-MS analysis. To make QCLMS accessible to a broader research community we developed a workflow that integrates the established software tools MaxQuant for spectra pre-processing, Xi for cross-linked peptide identification and finally Skyline for quantification (MS1 filtering). Out of the 221 unique residue pairs identified in our sample, 146 (66% of those identified) could be imported into Skyline and 124 (84% of those imported) were subsequently quantified with coefficient of variation (CV) values of 14% (injection replica) and 32% (reaction replica). Thus our results demonstrate that the reproducibility of QCLMS is in line with the reproducibility of general quantitative proteomics and we establish a robust workflow for MS1-based quantitation of cross-linked peptides.
2018-01-02 | PXD007250 | Pride
Project description:In order to test the usability of the new MS feature detection algorithm Dinosaur, 8 samples were analyzed. These were selected to represent different proteomics experiments and cover the full range of sample different complexities, from synthetic peptides to whole tissue lysate. This project evolves around the development of a new MS1 feature detection tool, and the files were only used for MS1 feature detection and analysis. Therefore, no identification files exist and there is no scientific interest in generating these.
2016-06-08 | PXD003405 | Pride